Pricing Log in Create free account

Ascendis Pharma A/S (ASND) vs BioMarin Pharmaceutical Inc. (BMRN)

Ascendis Pharma A/S and BioMarin Pharmaceutical Inc. are both Biotechnology companies. Ascendis Pharma A/S is the larger, with a market value of $14.9B against $10.9B — 1.4× the size. Ascendis Pharma A/S trades at the lower P/E: 16.3× against 144×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against 11.2%. Ascendis Pharma A/S has the higher net margin (71.2% vs 2.14%) and the higher return on invested capital (15.1% vs 0.97%). Across the 22 metrics below, Ascendis Pharma A/S leads on 17 and BioMarin Pharmaceutical Inc. on 5.

Valuation

Metric ASND BMRN Biotechnology median
P/E 16.28 143.89 8.50
P/S 11.99 3.10 9.71
P/B 8.70 1.67 2.13
Price to free cash flow 37.49 14.59 20.82
EV/EBITDA 43.91 46.69 0.64
EV/Sales 11.64 4.08 9.21
Earnings yield 6.14% 0.69% (33.15%)
Free cash flow yield 2.67% 6.85% (25.50%)

Profitability

Metric ASND BMRN Biotechnology median
Gross margin 91.26% 76.12% 65.16%
Operating margin 24.84% 4.38% 0.00%
Net margin 71.20% 2.14% 0.00%
Free cash flow margin 31.97% 21.28% 0.00%
Return on equity 118.44% 1.18% (56.36%)
Return on assets 44.34% 0.76% (48.04%)
Return on invested capital 15.07% 0.97% 0.00%

Growth

Metric ASND BMRN Biotechnology median
Revenue growth (TTM) 125.98% 11.20% 6.02%
EPS growth (last fiscal year) 39.89% (18.55%) 30.26%
Revenue growth, 5-year CAGR 152.47% 11.60% 9.41%
Net income growth, 5-year CAGR 0.00% (16.39%) 0.00%

Health

Metric ASND BMRN Biotechnology median
Debt to equity 0.31 0.66 0.00
Current ratio 2.99 2.39 4.72
Net debt to EBITDA (2.16) (1.99) 0.96

Dividend

Metric ASND BMRN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ASND BMRN Biotechnology median
Market cap 14.88b 10.85b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack